<code id='FF9EDC4455'></code><style id='FF9EDC4455'></style>
      • <acronym id='FF9EDC4455'></acronym>
      <center id='FF9EDC4455'><center id='FF9EDC4455'><tfoot id='FF9EDC4455'></tfoot></center><abbr id='FF9EDC4455'><dir id='FF9EDC4455'><tfoot id='FF9EDC4455'></tfoot><noframes id='FF9EDC4455'>
      • <optgroup id='FF9EDC4455'><strike id='FF9EDC4455'><sup id='FF9EDC4455'></sup></strike><code id='FF9EDC4455'></code></optgroup>
        5. <b id='FF9EDC4455'><label id='FF9EDC4455'><select id='FF9EDC4455'><dt id='FF9EDC4455'><span id='FF9EDC4455'></span></dt></select></label></b><u id='FF9EDC4455'></u>
          <i id='FF9EDC4455'><strike id='FF9EDC4455'><tt id='FF9EDC4455'><pre id='FF9EDC4455'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-27 16:05:40 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：7558
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Drastic changes should bring profitability, startup health insurers say
                                
                            
          Next article：  
                                      
                                          Psychedelics group wrestles with new pharma identity
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles